{
    "course title": "22449 Introduction to Biomedical product development",
    "Danish title": "Introduktion til medikoteknisk produktudvikling",
    "Language of instruction": "English",
    "Point( ECTS )": "5",
    "Course type": "MSc\nGeneral competence course (MSc), Biomedical Engineering\nProgramme specific course (MSc), Biomedical Engineering",
    "Schedule": "Autumn E4B (Fri 8-12)",
    "Location": "Campus Lyngby",
    "Scope and form": "13 lessons regarding biomedical engineering product development topics. After each lecture the students will work in smaller project groups for 2-3 hours. Max. 6 - 8 students in each project group.",
    "Duration of Course": "13 weeks",
    "Date of examination": "E4B, F4B",
    "Type of assessment": "Written examination\nThe final, two-hour Multiple Choice Qustions (MCQ) exam.",
    "Exam duration": "Written exam: 2 hours",
    "Aid": "All Aid - no access to the internet",
    "Evaluation": "7 step scale , external examiner",
    "Previous Course": "22435",
    "Responsible": "Morten Togo Sørensen , mortsor@dtu.dk",
    "Course co-responsible": "Erik Vilain Thomsen (Primary contact person) , Lyngby Campus, Building 344, Ph. (+45) 4525 5766 , ervt@dtu.dk",
    "Department": "22 Department of Health Technology",
    "Registration Sign up": "At the Studyplanner",
    "General course objectives": "General course objectives\nThe objectives of the course are to give the participants a practical understanding and knowledge about general aspects and different phases of biomedical engineering innovation and product development, documentation, clinical evaluation, regulatory requirements, standards, manufacturing, marketing, sales, service, complaint handling and sustainability aspects.",
    "Learning objectives": "A student who has met the objectives of the course will be able to:\nevaluate and provide constructive criticism of own and others suggestions of innovative ideas and concepts for new biomedical engineering products on the market.\nspecify a cross functional developing team and a product development model for a specific biomedical engineering product project and identify relevant critical milestones in a time schedule plan for such a development.\nevaluate and specify general technical and clinical quality safety issues regarding requirements and needs of a biomedical engineering product.\ntranslate customer needs and expectations to product specifications.\ndetermine and evaluate general health hazard risks (Health Hazard Evaluation) for biomedical engineering products based on clinical and technical as well as regulatory requirements.\ndescribe and evaluate high failure rates of certain components by calculating e.g. MTBF – Mean Time Between Failure of different biomedical engineering products in relation to the reliability needs of such components.\nidentify and outline human factors and limitations of importance for the design of biomedical engineering systems and equipment for efficient, safe, effective and reliable operation with a sustainable imprint.\ndescribe the process of how to verify and validate technical design parameters and performance data for a given medical device.\ndescribe and evaluate technical quality assurance features operating a given biomedical engineering product in use.\noutline an overall company organization as well as a quality assurance system for biomedical engineering product manufacturing.\ndescribe various regulatory demands and requirements related to marketing and selling biomedical engineering products in the US (FDA) and Europe (EU Regulations).\ndescribe and evaluate a general CAPA-system (Corrective and Preventive Actions) dealing with customer complaints and risk assessment regarding biomedical engineering products on the market in relation to regulatory issues.",
    "Content": "The course deals with the important clinical, technical, and regulatory documentation issues (US and Europe) concerning product development, testing, preclinical and clinical research, manufacturing, marketing, sales and service support as well as corrective and preventive actions and health hazard analysis a biomedical engineering company has to deal with in the European and US markets.",
    "Course literature": "Paul H King, Richard C Fries, Design of Biomedical Devices and Systems2nd ed. ISBN 978-1-4200-6179-6 or similar.\nLecture material as slides.\nSecondary lecture materials including recent biomedical engineering papers on the subject of biomedical engineering product development, manufacturing, marketing and service in general that can be downloaded from the internet.",
    "Remarks": "During the course the will be guest lectures by specialists from Danish companies. E.g. clinical evaluation, risk analysis, patents and intellectual property.",
    "Last updated": "27. maj, 2024"
}